Acquisitions (Schedule Of Revenue And Income And Net Loss Included In Condensed Consolidated Statements of Operations) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Revenue	$ 39,882	$ 98
Net (loss) income attributable to Endo International plc ordinary shareholders	(436,912)	15,349
Paladin Labs Inc. [Member]
Business Acquisition, Equity Interests Issued or Issuable [Line Items]
Revenue		24,822
Net (loss) income attributable to Endo International plc ordinary shareholders		$ 3,685
Basic and diluted net loss per share (usd per share)		$ 0.03